SCHEMBL4014511

SCHEMBL4014511

O=C(O)CCCOS(=O)(=O)C(F)(F)F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.40
SLC22A6 Q4U2R8 1/20 0.40
TSHR P16473 4/20 0.39
NFKB1 P19838 1/20 0.39
PMP22 Q01453 1/20 0.39
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CAMK2A Q9UQM7 1/20 0.36
FFAR4 Q5NUL3 3/20 0.36
FNTA P49354 1/20 0.35
FNTB P49356 1/20 0.35
APEX1 P27695 1/20 0.34
GABRR3 A8MPY1 1/20 0.34
GABRP O00591 1/20 0.34
GABRD O14764 1/20 0.34
HDAC3 O15379 1/20 0.34
GABBR2 O75899 1/20 0.34
CYP1A2 P05177 1/20 0.34
THRB P10828 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15619097 0.94 ALDH1A1 (0.45) LMNASLC22A6TSHRNFKB1PMP22
SCHEMBL4381355 0.92 ALDH1A1 (0.48) LMNASLC22A6TSHRNFKB1PMP22
SCHEMBL5238163 0.87 CA2 (0.40) LMNASLC22A6TSHRNFKB1PMP22
SCHEMBL575713 0.82 CA2 (0.44) LMNATSHRCA1CA2ALDH1A1
SCHEMBL576009 0.82 CA2 (0.44) LMNATSHRCA1CA2ALDH1A1
SCHEMBL23291930 0.80 CA2 (0.46) LMNATSHRCA1CA2ALDH1A1
SCHEMBL14779178 0.80 CA2 (0.46) LMNATSHRCA1CA2ALDH1A1
SCHEMBL4952312 0.80 CA2 (0.46) LMNATSHRCA1CA2ALDH1A1
SCHEMBL2735589 0.80 CA2 (0.46) LMNATSHRCA1CA2ALDH1A1
SCHEMBL8398329 0.80 CA2 (0.46) LMNATSHRCA1CA2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009080722-A2 CARBOXYLIC DERIVATIVES FOR USE IN THE TREATMENT OF CANCER CRYSTAX PHARMACEUTICALS, S.L. (ES) 2009-07-02 WO disclosed
EP-0365045-A1 Perhydrothiazepine derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1990-04-25 EP disclosed